IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy
Under the agreement, IBA will support the researchers in conducting a series of projects designed to evaluate the cost-effectiveness of proton therapy across multiple cancer indications, considering clinical outcomes, toxicity reduction, and broader economic impacts
June 10, 2026